Koyfin Home > Directory > Health Care > Albireo Pharma Inc > EBITDA

Albireo Pharma Inc EBITDA Chart (ALBO)

Albireo Pharma Inc annual/quarterly EBITDA from 2015 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Albireo Pharma Inc EBITDA for the quarter ending June 06, 2020 was $-18m a -13.31% increase of 2m year over year
  • Albireo Pharma Inc EBITDA for the last 12 months ending June 06, 2020 was $-78m a 16.24% decrease of -13m year over year
  • Albireo Pharma Inc Annual EBITDA for 2019 was $-61m a 37.92% decrease of -23m from 2018
  • Albireo Pharma Inc Annual EBITDA for 2018 was $-38m a 25.93% decrease of -10m from 2017
  • Albireo Pharma Inc Annual EBITDA for 2017 was $-28m a 76.25% decrease of -21m from 2016
Other Income Statement Metrics:
  • Albireo Pharma Inc Net Income for the quarter ending December 12, 2018 was $-16m a 89.79% decrease of -14m year over year
  • Albireo Pharma Inc Total Revenue for the quarter ending September 09, 2018 was $0m a 100.42% increase of 0m year over year
View Chart On Koyfin

Quarterly ALBO EBITDA Data

06/2020$-18m
03/2020$-30m
12/2019$-10m
09/2019$-21m
06/2019$-15m
03/2019$-15m
12/2018$-14m
09/2018$-13m
06/2018$-10m
03/2018$-1m

Annual ALBO EBITDA Data

2019$-61m
2018$-38m
2017$-28m
2016$-7m
2015$-5m
2014$-6m